For the 4th year in a row, CDH International has attended the BioTechX conference, which brings together 1000’s of members of the BioTech and Pharmaceutical industries. This year, our President, Dawn Ireland, led a Patient Advocacy track at the event to give a voice to not only Congenital Diaphragmatic Hernia patients a voice, but all patients a voice.
We are especially grateful to our Medical Advisory Board Members, Dr. Wendy Chung, Dr. Augusto Zani and the CDH Study Group’s Ashley Ebanks for participating, as well as our CDH Registry Manager, Jason Miller, and 10 other Rare Disease Patient Advocates.
It was a very successful event that led to new research collaborations in Europe, as well as more opportunities for Patients to have a seat at industry events.
